Newsroom Careers Contact Us

Manufacturing

Manufacturing Capabilities

We manufacture wide range of dosage forms complying to USFDA standard.

  • SOLID ORAL DOSAGE FORMS (TABLETS, CAPSULES, POWDERS, SACHETS, PELLETS AND BEADS)
  • PARENTERAL DOSAGE FORMS (LIQUID AND LYOPHILIZED POWDERS)
  • COMPLEX GENERICS (MODIFIED RELEASE, BILAYER, MUPS AND OCAS)
MANUFACTURING FACILITIES

Malaysia

Our manufacturing facilities in Bandar Enstek provide robust business connectivity to the regional market, benefiting from a strategic location less than 5km away from Kuala Lumpur International Airport (KLIA).

Spanning over 12 acres of land, our manufacturing facilities were designed by an internationally renowned European pharma engineering firm, complying to USFDA, NPRA Malaysia and PIC/S regulatory requirements and undergoing GMP accreditation from EU and WHO Geneva.

GENERAL PHARMACEUTICAL MANUFACTURING FACILITY

SYNERGY

Synergy is a finished products manufacturing facility based in Bandar Enstek, Negeri Sembilan to manufacture general pharmaceutical products.

  • Synergy is the FIRST pharmaceutical manufacturing facility in Malaysia and the only in Southeast Asia with USFDA accreditation.
  • The manufacturing facility is PIC/S approved GMP facility.
  • Synergy is also a Halal compliant manufacturing facility.
  • It has an annual production capacity of 2 billion tablets and capsules.
  • Explore Our CMO
"
ONCOLOGY FINISHED PRODUCTS MANUFACTURING FACILITY

CELSUS

Celsus is Southeast Asia’s FIRST fully automated, high containment (OEB5) finished products manufacturing facility for oncology products.

  • Celcus is the FIRST facility in Malaysia to received approval from USFDA and undergoing GMP accreditation from EU and WHO Geneva.
  • The manufacturing facility is a PIC/S approved GMP facility.
  • It is also complying to the highest safety and environmental standards of OSHA.
  • Explore Our CMO
ONCOLOGY API MANUFACTURING FACILITY

GALEN

Galen is the FIRST Oncology API manufacturing facility in Southeast Asia.

  • It is also the FIRST Oncology API facility to be accredited by USFDA, EU, PIC/S and GMP
  • It is designed to handle multi-stage chemical synthesis and multi-products at a time
GENERAL PHARMACEUTICAL MANUFACTURING FACILITY IN UZBEKISTAN

SYNERGY II

Located in the heart of Uzbekistan's capital city of Tashkent, SYNERGY II was acquired as part of a long-term vision to Novugen's global presence. The facility has a capacity to cater to the whole CIS region and the neighbouring countries.

  • State-of-the-art facilities engineered to the highest quality & safety standards
  • Annual capacity of 1 billion tablets
  • Capable to produce various dosage forms like sachets, syrups, vials and other dosage forms.
Uzbekistan
ONCOLOGY FINISHED PRODUCTS MANUFACTURING FACILITY, PAKISTAN

CELSUS II

CELSUS II is the FIRST Oncology Finished Products manufacturing plant in Pakistan.

  • Capable to produce injectables and oral solid dosage forms.
  • Capacity to produce 125Mn tablets & capsules annually
  • Designed to meet GMP quality & safety standards of WHO Geneva.
Highest Quality Standards

Quality

Our obsession for quality drives the company to achieve the highest standards for our products and services. This is aligned with our strategy and business philosophy to comply to USFDA and EU requirements through our day-to-day operations.

Compliance Systems

Our regulations and compliance systems assure pre-qualification of material vendors. We operate with stringent in-process system that provide control over any changes and documentation.